A significant part of FluidDA’s core business consists of developing and applying novel image processing methods. Data from clinical trials can be centralized on local servers and analyzed efficiently. Typically the efficiency of therapies can be assessed in detail using image modalities such as CT, MRI, PET and SPECT. FluidDA has substantial experience in respiratory, sleep, musculoskeletal and cardiovascular medicine.